Form 424B3 1st FRANKLIN FINANCIAL
Filed Pursuant to Rule 424(b)(3)SEC File #333-2956931st FRANKLIN FINANCIAL CORPORATIONVARIABLE RATESUBORDINATED DEBENTURESPERIODS OF OCTOBER 1, 2026 THRU OCTOBER 7, 2026ANDOCTOBER 8, 2026 THRU OCTOBER 14, 2026Period of October 1, 2026 Thru October 7, 2026EffectiveYield (a)InterestRate (b)InterestAdjustmentPeriod (c)MinimumInvestmentAmount1.771.75 1 Month$500.001.771.75 3 Months$500.004.604.50 6 Months$500.005.135.00 1 Year$500.005.135.00 2... (continue reading...)
Form 8-K Vylor Inc. For: Oct 01
false 0002128626 0002128626 2026-10-01 2026-10-01
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of Earliest Event Reported): October 1, 2026
Vylor Inc.
(Exact Name of Registrant as Specified in Its Charter)
Delaware 001-43376 41-2930124
(State or other jurisdiction
of... (continue reading...)
Form 8-K PARKERVISION INC For: Oct 01
false
0000914139
0000914139
2026-10-01
2026-10-01
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
______________
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): October 1, 2026
PARKERVISION, INC.
(Exact Name of Registrant as Specified in Charter)
Florida
... (continue reading...)
Form D FreeFall Aerospace, Inc.
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color:... (continue reading...)
Form 8-K SpyGlass Pharma, Inc. For: Oct 01
0001778922False00017789222026-10-012026-10-01UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549FORM 8-KCURRENT REPORTPursuant to Section 13 or 15(d)of The Securities Exchange Act of 1934Date of Report (Date of earliest event reported): October 1, 2026SpyGlass Pharma, Inc.(Exact name of registrant as specified in its charter)Delaware001-4310583-3044245(State or other jurisdiction of incorporation)(Commission File Number)(IRS Employer Identification... (continue reading...)
More SEC Filings
View Older Stories-
Form ATS-N/UA NATIONAL FINANCIAL SERVI
-
Form 6-K Ferrovial N.V. For: Oct 01
-
Form 8-K Orchestra BioMed Holding For: Oct 01
-
Form 485BXT Tidal Trust V
-
Form 8-K EIDP, Inc. For: Oct 01 Filed by: Corteva, Inc.
-
Form 424B2 CITIGROUP INC
-
Form 8-K FIRST MERCHANTS CORP For: Oct 01
-
Form N-CSRS Natixis Funds Trust IV For: Jul 31
-
Form 8-K Azitra, Inc. For: Oct 01
-
Form CERT Chilwa Minerals Ltd
-
Form 497J COLUMBIA FUNDS SERIES
-
Form SC TO-T/A ACV Auctions Inc. Filed by: COPART INC
-
Form 8-K Aptera Motors Corp For: Oct 01
-
Form 8-K AIRGAIN INC For: Sep 29
-
Form DEFA14A Strategy Inc
-
Form NRSRO-UPD A.M. Best Rating Service
-
Form 8-K Evommune, Inc. For: Oct 01
-
Form 8-K Strategy Inc For: Sep 30
-
Form 424B5 Antelope Enterprise Hold
-
Form 8-K RADNOSTIX INC For: Sep 28
-
Form FWP Hashdex Nasdaq CME Crypt Filed by: Hashdex Nasdaq CME Crypto Index ETF
-
Form 4 CERENOME, INC. For: Oct 01 Filed by: Guse Kyle
-
Form 4 CERENOME, INC. For: Oct 01 Filed by: Sims Andrew John Hugh MacIntyre
-
Form 6-K SILICOM LTD. For: Oct 01
-
Form 4 CERENOME, INC. For: Oct 01 Filed by: HEDRICK MARC H
-
Form 8-K Allarity Therapeutics, For: Sep 30
-
Form 6-K Antelope Enterprise Hold For: Oct 01
-
Form 4 CERENOME, INC. For: Oct 01 Filed by: van Es-Johansson An
-
Form 4 CERENOME, INC. For: Oct 01 Filed by: Hawkins Richard J
-
Form 4 CERENOME, INC. For: Oct 01 Filed by: ANDREWS RONALD ASBURY
-
Form 4 CERENOME, INC. For: Oct 01 Filed by: Clowes Howard
-
Form 6-K Radiopharm Theranostics For: Oct 01
-
Form 8-K NEKTAR THERAPEUTICS For: Oct 01
-
Form 8-K USA Rare Earth, Inc. For: Oct 01
-
Form 425 Armada Acquisition Corp. Filed by: Armada Acquisition Corp. II
-
Form 4 FILANA THERAPEUTICS, For: Sep 29 Filed by: Barry Richard
-
Form 4 Uxin Ltd For: Sep 30 Filed by: Dai Kun
-
Form 8-K Armada Acquisition Corp. For: Sep 30
-
Form 8-K Veritone, Inc. For: Sep 30
-
Form 6-K POWERBANK Corp For: Oct 01
-
Form 8-K Toast, Inc. For: Sep 28
-
Form 8-K Brightline Interactive, For: Oct 01
-
Form 8-K Valion Bio, Inc. For: Sep 30
-
Form 8-K Vylor Inc. For: Oct 01
-
Form 144 ORAMED PHARMACEUTICALS Filed by: Gabay Avraham
-
Form 8-K EIDP, Inc. For: Oct 01 Filed by: Corteva, Inc.
-
Form 144 ORAMED PHARMACEUTICALS Filed by: Hexter Joshua
-
Form 8-K Monte Rosa Therapeutics, For: Oct 01
-
Form SC TO-I/A Arbutus Biopharma Corp Filed by: Arbutus Biopharma Corp
-
Form F-X TSUKISHIMA HOLDINGS CO., Filed by: Mitsubishi Kakoki Kaisha, Ltd.

